BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18790253)

  • 1. Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients.
    Akutsu N; Iwashita C; Maruyama M; Ootsuki K; Ito T; Saigo K; Kenmochi T
    Transplant Proc; 2008 Sep; 40(7):2416-8. PubMed ID: 18790253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review.
    Song T; Rao Z; Tan Q; Qiu Y; Liu J; Huang Z; Wang X; Lin T
    Medicine (Baltimore); 2016 Apr; 95(14):e3173. PubMed ID: 27057842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
    Heidenhain C; Puhl G; Neuhaus P
    Exp Clin Transplant; 2009 Sep; 7(3):180-3. PubMed ID: 19715529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Posterior reversible encephalopathy syndrome (PRES) after kidney transplantation: a case report].
    Ueda N; Kawamura M; Nakazawa S; Hirai T; Kishikawa H; Nishimura K
    Hinyokika Kiyo; 2014 Aug; 60(8):387-92. PubMed ID: 25179989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible posterior leukoencephalopathy syndrome (RPLS) in a heart transplant recipient treated by substitution of cyclosporine A with tacrolimus.
    Oda N; Kato TS; Hanatani A; Niwaya K; Nakatani T; Ishibashi-Ueda H; Kitamura S; Hashimura K; Kitakaze M; Komamura K
    Intern Med; 2010; 49(11):1013-6. PubMed ID: 20519818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin Inhibitor-Induced Pain Syndrome in ABO-Incompatible Living Kidney Transplantation: A Case Report.
    Ishida S; Kato M; Fujita T; Funahashi Y; Sassa N; Matsukawa Y; Yoshino Y; Yamamoto T; Katsuno T; Maruyama S; Gotoh M
    Transplant Proc; 2017; 49(1):163-166. PubMed ID: 28104127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.
    Teraoka S; Sato S; Sekijima M; Iwado K; Urashima Y; Kudo S; Kai K; Koyama I; Tojinbara T; Nakajima I; Fuchinoue S
    Transplant Proc; 2005 Mar; 37(2):791-4. PubMed ID: 15848533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior reversible encephalopathy syndrome after kidney transplantation in pediatric recipients: Two cases.
    Giussani A; Ardissino G; Belingheri M; Dilena R; Raiteri M; Pasciucco A; Colico C; Beretta C
    Pediatr Transplant; 2016 Feb; 20(1):68-71. PubMed ID: 26607205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.
    Burnett MM; Hess CP; Roberts JP; Bass NM; Douglas VC; Josephson SA
    Clin Neurol Neurosurg; 2010 Dec; 112(10):886-91. PubMed ID: 20800343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitor withdrawal and conversion to mycophenolate mofetil and steroids in cardiac transplant recipients with chronic renal failure: a word of caution.
    Groetzner J; Kaczmarek I; Schirmer J; Uberfuhr P; Gulbins H; Daebritz S; Meiser B; Reichart B
    Clin Transplant; 2008; 22(5):587-93. PubMed ID: 18460000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome.
    El Kabbaj D; Hassani M; Kadiri M; Mounach J; Ouhabi H; Haimeur C; Oualim Z
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):790-3. PubMed ID: 22805393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of calcineurin inhibitors (CNIs) and steroid avoidance immunosuppressive protocol among living donor kidney transplant recipients.
    Oh HK; Ding P; Satmary NA
    Yonsei Med J; 2004 Dec; 45(6):1143-8. PubMed ID: 15627310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reversible posterior leukoencephalopathy induced by tacrolimus in a renal transplant patient].
    Izquierdo Pajuelo MJ; Jiménez Delgado JD; Rangel Mayoral JF; Liso Rubio FJ
    Farm Hosp; 2009; 33(3):177-8. PubMed ID: 19712604
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation.
    Créput C; Blandin F; Deroure B; Roche B; Saliba F; Charpentier B; Samuel D; Durrbach A
    Liver Transpl; 2007 Jul; 13(7):1004-10. PubMed ID: 17600361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.